Try our Advanced Search for more refined results

July 08, 2014

Byrd v. Janssen Pharmaceuticals, Inc. et al

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. September 24, 2018

    Janssen Gets $1M Risperdal Breast-Growth Verdict Flipped

    A New York federal judge has overturned a $1 million verdict for a man who took Risperdal as a child and developed female breast tissue, agreeing with defendant Janssen that it could not have warned of the condition on the label and that the trial was biased by a lawyer's mention of his own childhood bullying.

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login